Liraglutide: Best Telehealth Providers for Weight Loss Management (2026)
A GLP-1 receptor agonist administered daily for chronic weight management. FDA-approved as Saxenda for obesity and as Victoza for type 2 diabetes. One of the first GLP-1 medications widely used for weight loss before semaglutide.
Reviewed by Dr. James Okafor, PharmDPharmDLiraglutide at a Glance
Category
Weight Loss Management
Administration
Subcutaneous injection (daily)
Telehealth Providers
4 compared
Price Range
$200 – $299/mo
Typical Dose
0.6mg escalating to 3mg
Frequency
Once daily
Protocol Duration
Ongoing
Prescription
Required
Research highlight: The LEADER trial demonstrated liraglutide reduces the risk of major adverse cardiovascular events (MACE) by 13% in patients with type 2 diabetes and established cardiovascular disease — a key differentiator among GLP-1 agonists.
What is Liraglutide Used For?
Also known as: Saxenda, Victoza
- Weight loss
- Appetite suppression
- Blood sugar regulation
- Cardiovascular risk reduction
How Liraglutide Works
Liraglutide is a GLP-1 receptor agonist with 97% sequence homology to native GLP-1. It works by activating GLP-1 receptors in the hypothalamus to reduce appetite and increase satiety, slowing gastric emptying, stimulating glucose-dependent insulin secretion, and reducing glucagon. As a daily injection (vs. weekly semaglutide), its shorter half-life allows for quicker dose adjustments. FDA-approved as Victoza for type 2 diabetes and Saxenda for obesity.
LiraglutideDosing & Administration
| Typical Dose | 0.6mg escalating to 3mg |
| Frequency | Once daily |
| Protocol Duration | Ongoing |
| Route | Subcutaneous injection (daily) |
Note: FDA-approved for adolescents 12-17
Dosing information is for educational purposes only. Your prescribing physician will determine the appropriate dose based on your medical history and treatment goals.
What to Expect from Liraglutide
Appetite suppression and reduced food intake begin within the first week. Average weight loss in the SCALE trials was 8% total body weight at 56 weeks on the 3mg dose — less than semaglutide or tirzepatide but meaningful for many patients. Blood glucose improvements in type 2 diabetes are typically seen within 4–8 weeks.
Who Should Consider Liraglutide?
- Patients who prefer daily injection dosing flexibility
- Those with insurance coverage for Saxenda/Victoza
- Cardiovascular risk patients with type 2 diabetes
- Adolescents aged 12-17 with obesity (FDA-approved indication)
Liraglutide Side Effects
- Nausea (very common, especially at initiation)
- Vomiting
- Diarrhea
- Constipation
- Headache
- Injection site reactions
- Rare: pancreatitis, gallbladder disease, thyroid C-cell tumors (rat models; human relevance unclear)
This is not a complete list of side effects. Always consult your prescribing physician before starting Liraglutide.
4 Telehealth Providers Offering Liraglutide
Sorted by lowest price. All providers require a prescription from a licensed physician.
| Provider | Price | Dose | Rating | Consultation | Lab Testing |
|---|---|---|---|---|---|
| Heally San Francisco, CA | $200/monthly | 0.6-3mg/day | 3.9/5 | Video Telehealth | Not included |
| Defy Medical Tampa, FL | $220/monthly | 0.6-3mg/day | 4.1/5 | Video Telehealth | Included |
| Evolve Telemed San Diego, CA | $250/monthly | 0.6-3mg/day | 4.0/5 | Video Telehealth | Included |
| Calibrate New York, NY | $299/monthly | 0.6-3mg/day | 4.0/5 | Video Telehealth | Included |
How to Choose the Best Telehealth Provider for Weight Loss Management
Not all online weight-loss programs are equal. These are the criteria we evaluate when ranking telehealth providers for weight loss medications.
Licensed Medical Supervision
The best providers require a licensed physician or NP to review your health history and approve your prescription — not just an intake algorithm. Asynchronous intake is fine; skipping real medical review is not.
Transparent Per-Dose Pricing
Weight loss programs range from $99 to $500+/month for semaglutide. Look for providers that clearly state the dose included and cost per mg so you can compare programs on equal terms.
Compounding Pharmacy Quality
Compounded medications must come from an FDA-registered 503A or 503B pharmacy. Ask which pharmacy your provider uses and verify its accreditation — sterility and potency standards vary significantly.
Proper Dose Titration
GLP-1 medications should start at a low dose and escalate gradually over weeks. Providers who skip titration to speed results are prioritizing revenue over your safety.
Lab Monitoring
Baseline labs (metabolic panel, HbA1c, lipids) and periodic follow-up are standard of care for GLP-1 therapy. Providers who require or include labs are practicing at a higher standard.
Long-Term Support
Weight management is a long-term commitment. Look for providers with clear refill processes, messaging access to your care team, and supply chain stability beyond the promotional first month.
Frequently Asked Questions About Liraglutide
Why would I choose liraglutide over semaglutide?
Semaglutide (weekly injection, 15% average weight loss) has largely replaced liraglutide (daily injection, ~8% average weight loss) for weight management in most clinical settings. Liraglutide remains relevant for patients who need daily dosing flexibility, those with insurance coverage for Saxenda/Victoza, and patients who had a poor response to semaglutide but tolerate liraglutide better.
Is liraglutide approved for cardiovascular protection?
Yes — the LEADER trial showed liraglutide reduces the risk of major adverse cardiovascular events (MACE) by 13% in patients with type 2 diabetes and established cardiovascular disease. This is one of its key advantages in the diabetic population with cardiac risk.
Can liraglutide be used in pediatric patients?
Saxenda (liraglutide 3mg) received FDA approval for weight management in adolescents aged 12–17 with obesity in 2020, making it one of the few approved pharmacological options for this age group. Use in children under 12 is not approved.
Does liraglutide have a black box warning?
Yes — liraglutide carries an FDA black box warning about thyroid C-cell tumors observed in rodent studies. It is contraindicated in patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Human relevance of the rodent finding remains uncertain.
Liraglutide Alternatives for Weight Loss Management
Compare other weight loss management peptides available through telehealth.
AOD-9604
A modified fragment (amino acids 176-191) of human growth hormone designed to stimulate fat metabolism without the growth-promoting effects of full HGH. Studied as a targeted fat-loss peptide.
Retatrutide
A next-generation triple agonist targeting GLP-1, GIP, and glucagon receptors simultaneously. Phase 3 clinical trials show weight loss exceeding tirzepatide, positioning it as the most potent anti-obesity peptide in development.
Semaglutide
A GLP-1 receptor agonist originally developed for type 2 diabetes, now widely prescribed for weight management. Reduces appetite and slows gastric emptying.
Tirzepatide
A dual GIP/GLP-1 receptor agonist for weight management and type 2 diabetes. Clinical trials show significant weight reduction, often exceeding semaglutide results.